Clinical Trials Browser

Phase 1/2 × Interventional × Bone Neoplasms × Clear all

NCT07560410 2026-05-11

Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)

Phase 1/2 Not yet recruiting

Bone Neoplasms

NCT05395741 2026-03-25

Regbone

Phase 1/2 Active not recruiting

Bone Neoplasms, Sarcoma, Ewing, Osteosarcoma

NCT03965234 2026-03-17

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Phase 1/2 Recruiting

GastrointestinalSarcoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

NCT06562673 2025-12-29

IACE-OS

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT04310410 2024-02-07

PRE-FURTHER

Phase 1/2 Completed

Bone Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Radiation Injuries

NCT04433221 2020-06-16

Combination Immunotherapy Targeting Sarcomas

Phase 1/2 Unknown

Bone Neoplasms, Sarcoma, Sarcoma, Ewing

NCT03356782 2020-06-11

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Phase 1/2 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Bone Neoplasms, Sarcoma, Sarcoma, Ewing

NCT01610570 2018-03-02

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

Phase 1/2 Terminated

8 enrolled 20 charts

Bone Neoplasms, Sarcoma, Sarcoma, Ewing

NCT02862288 2016-08-11

TherMO

Phase 1/2 Completed

GenitourinarySarcomaThoracic

Bone Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms